Ascorbic acid role in containment of the world avian flu pandemic.

In this Comment, the ultimate intent is to increase survival of the anticipated global flu pandemic. The apparent failure of "medicine" to provide a completely understood and logically based biochemical prevention and treatment for all influenzas (and many other viral diseases) may be an unavoidable result of the evolving complexity of the H5N1 virus. However, clinical experience cited in all accounts, including the 2003 to 2006 period, suggest that: (i) ascorbic acid is not being administered to humans infected or at risk for influenza, and (ii) ascorbic acid is (mistakenly) believed to be a vitamin ("vitamin C"). Proper use of ascorbic acid as described here could provide effective containment for the flu pandemic.

Controlling hyperglycemia as an adjunct to cancer therapy.

Hyperglycemia is commonly manifested in cancer patients. Although high intakes of sugar and refined carbohydrates and elevated blood glucose are strongly associated with the risk of cancer, much less is known about their effects on survival after cancer diagnosis. There is evidence that high carbohydrate intake is associated with poorer survival after diagnosis for early breast cancer. We measured glycated hemoglobin in a group of cancer patients (some with active disease and some in remission) and found a statistically significant lower average blood glucose in those in remission. Glycated hemoglobin provides an indication of average blood glucose over 2 to 3 months. The authors discuss lifestyle changes including diet and physical activity that can reduce average blood glucose. Ascorbic acid (AA) supplementation as an adjunct to cancer therapy is also considered. Furthermore, they present a biologically plausible explanation for how hyperglycemia can impair the actions of AA and damage immune effectiveness and hinder cancer survival. One mechanism is likely a reduction in intracellular AA; high intracellular levels of AA are necessary for optimal activity of the hexose monophosphate shunt. This metabolic pathway is important for maintaining proper cellular antioxidant status in immune cells including lymphocytes involved in cell-mediated immunity.

Ascorbic acid, glycation, glycohemoglobin and aging.

The glycation of proteins alters both their structure and function. These changes have been linked to diabetic disorders and aging. The glycation of hemoglobin is also used as a diagnostic tool; the extent of glycation being a reflection of blood glucose averaged over a two to three month period. Accurate measures of average blood sugar (e.g., glycohemoglobin (GHb)) are important in clinical management of diabetes, pregnancy, cancer, etc. Ascorbic acid (AA) can react with proteins, including hemoglobin, and possibly interfere with GHb measurements. Past reports on the impact of AA on in vivo glycation have been equivocal. We studied GHb in subjects supplementing up to 20 g AA daily and found that for each 30 micromol/L increase in plasma AA, GHb was reduced by approximately 0.1. These results suggest that high AA intake can depress glycation, reduce GHb and lead to a clinically relevant underestimation of average blood sugar. Because AA is the most commonly consumed dietary supplement, awareness of an AA-associated bias in GHb is imperative. Of even broader significance is the possibility of AA-mediated inhibition of glycation in all proteins and the implications for aging. Moreover, AA could contribute through several other mechanisms to slowing of human aging (e.g., antioxidant properties, acceleration of pentose phosphate pathway, replacement of structural proteins).

Aneurysm: prevention and nonsurgical repair.

The approximately 4000 'normal' mammals that synthesize ascorbic acid produce on average circa 50 mg/kg per day routinely. Although humans have the same needs as normal mammals, they do not produce ascorbic acid at all and, on average, ingest only circa 1 mg/kg per day. The normal mammals' much larger production enables them to continually renew structural proteins, including both collagen, a flexible but inelastic tissue, and elastin, the elastic connective tissue. As a result, many normal mammals maintain a 'youthful' appearance with little gross anatomical change from age of maturity (i.e, first estrus) to more than 20 times age of maturity. In stark contrast, the extremely small ascorbic acid intake of humans does not enable them to maintain a youthful flexibility and elasticity beyond possibly 6 times age of maturity (most have died before 8 times). This loss of youthful qualities in structural proteins results in susceptibility for many forms of deterioration in both appearance and properties of vascular and other structural tissues. One such deterioration is aortic aneurysm, a common cause of morbidity and mortality. We hypothesize herein that improved dietary intake of essential nutrients needed to enhance the renewal of all structural proteins can: (1). prevent this deterioration completely; and (2). cure even large aortic aneurysms without surgery.

Polyurethanes and childhood asthma.

BACKGROUND: Asthma is the most common chronic disease of children. Its prevalence in affluent nations has steadily and dramatically increased in recent decades. Genetic and environmental factors play a role in development of atopy and asthma. Imbalance in the immune system favoring respiratory diseases has been linked to exposure to environmental stressors (e.g, biological and chemical) very early in life. Isocyanates, used in the production of polyurethane, can elicit asthma and produce immune responses (e.g, antibodies, cytokines, etc.) typical of atopy. MATERIAL/METHODS: Numerous medical materials that directly contact human neonates are constructed of polyurethanes. A detailed survey and listing of such materials was undertaken in the neonatal unit of a large urban hospital. Representative samples of polyurethane-containing materials were tested for isocyanate residues using a semi-quantitative colorimetric method. RESULTS: Isocyanate residues were detected in wound dressings, adhesive films, oximetry sensors, etc, that directly contact neonatal skin. CONCLUSIONS: Dermal exposure to polyurethane and, thus, to isocyanates could occur early in life through contact with medical materials. In an animal model, dermal exposure to isocyanates leads to dermal sensitization and asthma. We postulate that dermal contact with polyurethane-containing medical materials may be involved in dysregulation of the neonatal immune system and could predispose infants to the development of childhood asthma.

On reducing the need for arthroplasty: benefits for patients and budgets.

The need for arthroplasty, especially in the hip, arises primarily because of failure to replace damaged structural proteins as a result of improper balance in essential nutrients. The principal failure is an inadequate production of elastin resulting in cartilage consisting primarily of a collagen that may be flexible but is not elastic. In spite of the fact that an excess of protein, with adequate lysine, is commonly consumed by the affluent societies, this lysine is not utilized because of the inadequate intake of ascorbic acid necessary for virtually every step of the structural protein synthetic reactions. Experiments in animals support these conclusions. It is anticipated that dietary correction in candidates for total hip replacement will be able to restore normal hip cartilage (with corresponding improvements of other structural protein deficits throughout the body) in less than a year. Adoption of this regimen should result in: (1) a greatly decreased need for arthroplasties; and (2) better results in those that are performed, with less failures and less need for revisions. The benefits include much less suffering for patients and far lower medical costs.